Cystic Fibrosis Devices Global Strategic Business Report 2024: Market to Reach $1.6 Billion by 2030 AbbVie, Allergan Plc, AstraZeneca at the Forefront


Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis Devices - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The global market for Cystic Fibrosis Devices is estimated at US$850.8 Million in 2023 and is projected to reach US$1.6 Billion by 2030, growing at a CAGR of 9.1% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.



Key Insights:

  • Regional Analysis: Gain insights into the U.S. market, estimated at $221.9 Million in 2023, and China, forecasted to grow at an impressive 13.5% CAGR to reach $410.4 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Cystic Fibrosis Devices Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Cystic Fibrosis Devices Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Cystic Fibrosis Devices Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as AbbVie, Allergan Plc, AstraZeneca, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

MarketGlass Platform

The report is enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

Key Attributes:

Report AttributeDetails
No. of Pages93
Forecast Period2023 - 2030
Estimated Market Value (USD) in 2023$850.8 Million
Forecasted Market Value (USD) by 2030$1600 Million
Compound Annual Growth Rate9.1%
Regions CoveredGlobal



MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Cystic Fibrosis Devices - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)

FOCUS ON SELECT PLAYERS (Total 42 Featured)

  • AbbVie
  • Allergan Plc
  • AstraZeneca
  • Bayer AG
  • Chiesi Farmaceutici S.p.A.
  • F. Hoffmann-La Roche AG
  • Genentech, Inc.
  • Gilead Sciences
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • Pharmaxis Ltd.
  • PTC Therapeutics
  • Vertex Pharmaceuticals Incorporated

For more information about this report visit https://www.researchandmarkets.com/r/vsumq7

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

 
Cystic Fibrosis Devices Market

Contact Data